CIK 0001534120
- Non-accelerated filer
- Smaller reporting company
Avalo Therapeutics, Inc.
Sign in to watch- Ticker
- AVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 450705648
- Phone
- +1 410-522-8707
- Business address
- 1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE, PA, 19087
- Former names
- Cerecor Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $395,474
- in 3 filings, $395K under 10b5-1 plans
Net −$395,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-01-24 | ARMISTICE CAPITAL, LLC Director | Conversion | +3,000,000 | 28,683,233 | ||
| 2020-01-24 | ARMISTICE CAPITAL, LLC Director | Conversion · Series B Convertible Preferred Stock | −600,000 | 1,257,143 | ||
| 2020-01-22 | ARMISTICE CAPITAL, LLC Director | Conversion | +5,000,000 | 25,683,233 | ||
| 2020-01-22 | ARMISTICE CAPITAL, LLC Director | Conversion · Series B Convertible Preferred Stock | −1,000,000 | 1,857,143 | ||
| 2019-12-31 | Persson Magnus Director | Grant or award · Stock Option (Right to Buy) | +2,682 | 2,682 | ||
| 2019-12-31 | Hacksell Uli Director | Grant or award · Stock Option (Right to Buy) | +11,016 | 1,106 | ||
| 2019-12-31 | Gutry Phil Director | Grant or award · Stock Option (Right to Buy) | +2,375 | 2,375 | ||
| 2019-12-10 | Miller Joseph M Chief Financial Officer | Purchase | +2,598 | $2.85 | $7K | 48,777 |
| 2019-12-10 | Harrell James Archie Jr Chief Commercial Officer | Purchase | +3,064 | $2.85 | $9K | 11,618 |
| 2019-12-10 | Calias Pericles Chief Scientific Officer | Purchase | +2,913 | $2.85 | $8K | 52,462 |
| 2019-09-30 | Persson Magnus Director | Grant or award · Stock Option (Right to Buy) | +4,411 | 4,411 | ||
| 2019-09-30 | Hacksell Uli Director | Grant or award · Stock Option (Right to Buy) | +1,819 | 1,819 | ||
| 2019-09-30 | Gutry Phil Director | Grant or award · Stock Option (Right to Buy) | +3,907 | 3,907 | ||
| 2019-09-06 | ARMISTICE CAPITAL, LLC Director | Purchase | +1,000,000 | $2.95 | $3.0M | 20,683,233 |
| 2019-09-06 | ARMISTICE CAPITAL, LLC Director | Purchase | +0 | 20,683,233 | ||
| 2019-09-04 | ARMISTICE CAPITAL, LLC Director | Purchase | +1,200,000 | $3.13 | $3.8M | 19,683,233 |
| 2019-08-30 | ARMISTICE CAPITAL, LLC Director | Purchase | +24,591 | $3.23 | $79K | 18,483,233 |
| 2019-08-29 | ARMISTICE CAPITAL, LLC Director | Purchase | +17,173 | $3.21 | $55K | 18,458,642 |
| 2019-08-27 | Pedder Simon Executive Chairman of the Bd | Purchase | +6,734 | $2.98 | $20K | 262,734 |
| 2019-08-23 | Phillips Matthew V Chief Commercial Officer | Grant or award | +512,500 | $1.07 | $548K | 512,500 |
Page 23 of 25 · 500 trades